Genky DrugStores Co., Ltd.

9267.T
Pharmaceutical Retailers
2026/08/21 Updated
Market Cap: $708.4M (¥112.6B)
Stock Price: $23.24 (¥3,695)
Exchange Rate: 1 USD = ¥158.98

[Genky DrugStores] Fiscal Year 2025 Performance and Store Strategy | June 2026

Genky DrugStores reports on FY2025 monthly sales, existing store sales, and customer traffic trends, along with the number of new and renovated stores. It also presents outlook and store strategy for the fiscal year ending June 2026.

Importance:
Page Updated: May 29, 2026
IR Disclosure Date: May 29, 2026

Key Figures

  • Total store count: Unknown (525 stores as of June 2026)
  • Number of new store openings: Unknown (11 stores in FY2025)
  • Specific figures for sales and profit are unavailable

AI要約

Performance Overview

Genky DrugStores announced monthly sales, existing store sales, and customer traffic trends for FY2025, indicating stable overall sales despite specific figures being undisclosed. The number of new and renovated stores is also reported, with continued store count expansion. The first-half results for the fiscal year ending June 2026 have been released, highlighting sales and customer trends.

Future Outlook and Store Strategy

The company plans to continue expanding and renovating stores, aiming to increase the total number of stores. While YoY trends for sales and traffic are not disclosed, efforts focus on maintaining existing store sales and growing through new store openings. Detailed earnings guidance and specific figures have not been disclosed, but emphasis is placed on store expansion and strengthening the customer base.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Genky DrugStores Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →